Company Filing History:
3 out of 180 
1 out of 2 Years Active: 2014-2019
Title: **Doo Jae Lee: Innovator in Pharmaceutical Chemistry**
Introduction
Doo Jae Lee is an accomplished inventor based in Seoul, South Korea, known for his significant contributions to pharmaceutical chemistry. With a total of four patents under his name, Lee’s work primarily focuses on innovative compounds aimed at advancing medical treatments.
Latest Patents
One of Lee's notable patents is related to an epidithiodioxopiperazine compound or its derivatives. This invention encompasses a method for preparing a compound that improves intracellular permeability and mimics the activity of 2-Cys-Prx in its reduced form. The patent also describes a pharmaceutical composition designed for preventing or treating vascular diseases, utilizing the epidithiodioxopiperazine compound as an active ingredient. Additionally, it includes a drug delivery device for local administration, as well as a composition aimed at inhibiting melanoma metastasis, ensuring a multifaceted approach to cancer treatment.
Career Highlights
Throughout his career, Doo Jae Lee has demonstrated a strong commitment to innovation in pharmaceutical research. His extensive knowledge and expertise allow him to develop groundbreaking solutions that address critical health challenges. His work has positioned him as a significant figure in the realm of drug development and delivery.
Collaborations
Doo Jae Lee has collaborated with notable individuals in his field, including Sang Won Kang and Dong Hoon Kang. Additionally, he has worked with reputable organizations such as the Ewha University-Industry Collaboration Foundation and Vasthera Co. Ltd., enhancing his research and development capabilities.
Conclusion
Doo Jae Lee stands out as a dedicated inventor, contributing significantly to the fields of medicine and pharmaceutical chemistry. His innovative work, especially in the development of epidithiodioxopiperazine compounds, showcases his commitment to creating effective therapeutic solutions and positioning him as a valuable contributor to ongoing medical advancements.